Tumor-stromal interactions in breast tumor progression - significance of histological heterogeneity of tumor-stromal fibroblasts

被引:19
作者
Hasebe, Takahiro [1 ]
机构
[1] Natl Canc Ctr Hosp East, Dept Pathol & Clin Labs, Kashiwa, Chiba 2778577, Japan
基金
日本学术振兴会;
关键词
breast; carcinoma; endothelial cell; fibroblast; fibrotic focus; INVASIVE DUCTAL CARCINOMA; CANCER-ASSOCIATED FIBROBLASTS; HISTOPATHOLOGICAL PROGNOSTIC PARAMETER; EARLY DISTANT RELAPSE; FIBROTIC FOCUS; GROWTH-FACTOR; LYMPH-NODE; UP-REGULATION; INTRATUMORAL FIBROBLASTS; SIGNIFICANT PREDICTORS;
D O I
10.1517/14728222.2013.757305
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Introduction: Existing pathological diagnostic protocols for breast cancer do not fully reflect the biological characteristics of tumor stromata. To improve the pathological diagnosis of breast cancer, a new pathological diagnostic method capable of assessing the degree of breast cancer malignancy based on the histological features of the tumor stroma is needed. Areas covered: The presence of a fibrotic focus (FF), which consists of fibroblasts or collagen fibers, and the presence of atypical tumor-stromal fibroblasts are significantly associated with nodal metastasis or distant-organ metastasis in patients with invasive ductal carcinoma (IDC) of the breast. FF is the only factor that is significantly associated with an increase in tumor angiogenesis. The importance of FF and atypical tumor-stromal fibroblasts clearly indicates that the malignant potential of IDC does not depend only on the biological characteristics of the tumor cell, but also on those of the tumor stroma. Expert opinion: The biological characteristics of fibroblasts forming an FF or atypical tumor-stromal fibroblasts probably differ from those of fibroblasts located outside an FF or ordinary tumor-stromal fibroblasts. Thus, similar to tumor cells, the heterogeneity of tumor-stromal fibroblasts probably influences the outcome of patients with IDC of the breast.
引用
收藏
页码:449 / 460
页数:12
相关论文
共 106 条
[1]   A mitotically active, cellular tumor stroma and/or inflammatory cells associated with tumor cells may contribute to intermediate or high Oncotype DX Recurrence Scores in low-grade invasive breast carcinomas [J].
Acs, Geza ;
Esposito, Nicole N. ;
Kiluk, John ;
Loftus, Loretta ;
Laronga, Christine .
MODERN PATHOLOGY, 2012, 25 (04) :556-566
[2]   Tumor Endothelial Cells Acquire Drug Resistance by MDR1 Up-Regulation via VEGF Signaling in Tumor Microenvironment [J].
Akiyama, Kosuke ;
Ohga, Noritaka ;
Hida, Yasuhiro ;
Kawamoto, Taisuke ;
Sadamoto, Yoshihiro ;
Ishikawa, Shuhei ;
Maishi, Nako ;
Akino, Tomoshige ;
Kondoh, Miyako ;
Matsuda, Aya ;
Inoue, Nobuo ;
Shindoh, Masanobu ;
Hide, Kyoko .
AMERICAN JOURNAL OF PATHOLOGY, 2012, 180 (03) :1283-1293
[3]   Tumor endothelial cells express epidermal growth factor receptor (EGFR) but not ErbB3 and are responsive to EGF and to EGFR kinase inhibitors [J].
Amin, DN ;
Hida, K ;
Bielenberg, DR ;
Klagsbrun, M .
CANCER RESEARCH, 2006, 66 (04) :2173-2180
[4]   Vascular proliferation is a prognostic factor in breast cancer [J].
Arnes, Jarle B. ;
Stefansson, Ingunn M. ;
Straume, Oddbjorn ;
Baak, Jan P. ;
Lonning, Per E. ;
Foulkes, William D. ;
Akslen, Lars A. .
BREAST CANCER RESEARCH AND TREATMENT, 2012, 133 (02) :501-510
[5]   Ethanol-induced in vitro invasion of breast cancer cells:: The contribution of MMP-2 by fibroblasts [J].
Aye, MM ;
Ma, CL ;
Lin, H ;
Bower, KA ;
Wiggins, RC ;
Luo, J .
INTERNATIONAL JOURNAL OF CANCER, 2004, 112 (05) :738-746
[6]   Multivariate prognostic evaluation of the mitotic activity index and fibrotic focus in node-negative invasive breast cancers [J].
Baak, JPA ;
Colpaert, CGA ;
van Diest, PJ ;
Janssen, E ;
van Diermen, B ;
Albernaz, E ;
Vermeulen, PB ;
Van Marck, EA .
EUROPEAN JOURNAL OF CANCER, 2005, 41 (14) :2093-2101
[7]   Under pressure: Stromal fibroblasts change their ways [J].
Bierie, B ;
Moses, HL .
CELL, 2005, 123 (06) :985-987
[8]   Survival of invasive breast cancer according to the Nottingham Prognostic Index in cases diagnosed in 1990-1999 [J].
Blamey, R. W. ;
Ellis, I. O. ;
Pinder, S. E. ;
Lee, A. H. S. ;
Macmillan, R. D. ;
Morgan, D. A. L. ;
Robertson, J. F. R. ;
Mitchell, M. J. ;
Ball, G. R. ;
Haybittle, J. L. ;
Elston, C. W. .
EUROPEAN JOURNAL OF CANCER, 2007, 43 (10) :1548-1555
[9]   Inhibition of p53 response in tumor stroma improves efficacy of anticancer treatment by increasing antiangiogenic effects of chemotherapy and radiotherapy in mice [J].
Burdelya, Lyudmila G. ;
Komarova, Elena A. ;
Hill, Jason E. ;
Browder, Timothy ;
Tararova, Natalia D. ;
Mavrakis, Lori ;
DiCorleto, Paul E. ;
Folkman, Judah ;
Gudkov, Andrei V. .
CANCER RESEARCH, 2006, 66 (19) :9356-9361
[10]   Interactions with Fibroblasts Are Distinct in Basal-Like and Luminal Breast Cancers [J].
Camp, J. Terese ;
Elloumi, Fathi ;
Roman-Perez, Erick ;
Rein, Jessica ;
Stewart, Delisha A. ;
Harrell, J. Chuck ;
Perou, Charles M. ;
Troester, Melissa A. .
MOLECULAR CANCER RESEARCH, 2011, 9 (01) :3-13